Burks R T, Sherman M E, Kurman R J
Department of Pathology, Virginia Commonwealth University Health Sciences Division, Medical College of Virginia, Richmond, USA.
Am J Surg Pathol. 1996 Nov;20(11):1319-30. doi: 10.1097/00000478-199611000-00003.
According to the International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization (WHO), stromal invasion, defined as destructive infiltrative growth, is the sole criterion used to distinguish serous borderline tumors from invasive serous carcinomas of the ovary. Although this criterion effectively identifies most malignant tumors, it does not permit the identification of a small subset of well-differentiated ovarian carcinomas that do not display destructive infiltrative growth but that may be associated with malignant behavior. In this study, we describe a group of such serous neoplasms that have distinctive morphologic features and that are often associated with progressive, invasive disease. We have designated these tumors micropapillary serous carcinomas (MPSC). They are characterized by a filigree pattern of highly complex micropapillae arising directly from large, bulbous papillary structures. The micropapillae are covered by round to cuboidal cells with a high nuclear-to-cytoplasmic ratio. Typical serous borderline tumors tend to display a hierarchical pattern of branching terminating in small papillae or tufts, and the cells covering the papillae tend to be more columnar and often ciliated compared with cells of MPSC. We reviewed more than 400 cases of serous ovarian borderline tumors and well-differentiated serous carcinomas and identified 26 cases of MPSC. Seventeen tumors lacked destructive infiltrative growth (noninvasive), and nine contained areas of invasion ranging from minimal to extensive. Eight of the 26 tumors were stage I, and none of the patients developed recurrence whether or not their tumors had demonstrable invasion. In contrast, of the 16 women presenting with stage II disease or higher and who had more than 1 year of follow-up, eight (50%) have either died of intra-abdominal carcinomatosis or are alive with carcinoma. Twenty-four (92%) of MPSCs contained areas of serous borderline tumor. The frequent association of MPSCs with serous borderline tumors suggests that MPSCs arise from the latter and may account for the few cases of serous borderline tumors that have been associated with progression to invasive carcinoma.
根据国际妇产科联合会(FIGO)和世界卫生组织(WHO)的定义,间质浸润被定义为破坏性浸润性生长,是区分卵巢浆液性交界性肿瘤与浸润性浆液性癌的唯一标准。尽管该标准有效地识别了大多数恶性肿瘤,但它无法识别一小部分高分化卵巢癌,这些癌不表现出破坏性浸润性生长,但可能与恶性行为相关。在本研究中,我们描述了一组具有独特形态特征且常与进行性浸润性疾病相关的浆液性肿瘤。我们将这些肿瘤命名为微乳头浆液性癌(MPSC)。它们的特征是由高度复杂的微乳头组成的细丝状图案,这些微乳头直接起源于大的球茎状乳头结构。微乳头被核质比高的圆形至立方形细胞覆盖。典型的浆液性交界性肿瘤倾向于表现出分支的分层模式,末端为小乳头或簇状,与MPSC的细胞相比,覆盖乳头的细胞往往更呈柱状且常有纤毛。我们回顾了400多例卵巢浆液性交界性肿瘤和高分化浆液性癌病例,确定了26例MPSC。17个肿瘤缺乏破坏性浸润性生长(非浸润性),9个肿瘤含有从最小到广泛的浸润区域。26个肿瘤中有8个为I期,无论肿瘤是否有可证实的浸润,患者均未出现复发。相比之下,16例患有II期或更高期疾病且随访超过1年的女性中,有8例(50%)死于腹腔内癌转移或仍患有癌症存活。24例(92%)MPSC含有浆液性交界性肿瘤区域。MPSC与浆液性交界性肿瘤的频繁关联表明MPSC起源于后者,可能解释了少数与进展为浸润性癌相关的浆液性交界性肿瘤病例。